Actively Recruiting
The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients
Led by Fudan University · Updated on 2021-09-02
100
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The breast cancer patients who received radiotherapy after mastectomy and breast reconstruction will be enrolled. The skin microbiome before radiotherapy and its changes after radiotherapy will be analyzed systematically to find out whether the skin microbiome is associated with the severity of radiation dermatitis.
CONDITIONS
Official Title
The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients
- Diagnosed with invasive breast cancer confirmed by pathology
- Have undergone mastectomy and breast reconstruction
- Scheduled to receive radiotherapy after breast reconstruction
- ECOG performance status score of 0 to 1
- Provided signed informed consent
You will not qualify if you...
- Previous radiotherapy to the breast or chest
- Presence of serious skin diseases such as systemic lupus erythematosus or skin sclerosis that prevent radiotherapy
- Pregnant women
- Unwilling or unable to attend regular follow-up visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
W
Wei Shi, MD, Ph.D
CONTACT
L
Li Zhang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here